Comparing Jushi (OTCMKTS:JUSHF) & FitLife Brands (NASDAQ:FTLF)

FitLife Brands (NASDAQ:FTLF) and Jushi (OTCMKTS:JUSHF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Insider and Institutional Ownership

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 21.7% of Jushi shares are held by institutional investors. 61.3% of FitLife Brands shares are held by insiders. Comparatively, 21.7% of Jushi shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Risk and Volatility

FitLife Brands has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Jushi has a beta of -0.62, indicating that its share price is 162% less volatile than the S&P 500.

Profitability

This table compares FitLife Brands and Jushi’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
FitLife Brands	13.38%	28.03%	15.13%
Jushi	-20.93%	N/A	-10.45%

Earnings and Valuation

This table compares FitLife Brands and Jushi”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$64.47 million	2.23	$5.30 million	$0.84	18.52
Jushi	$269.45 million	0.25	-$65.10 million	($0.24)	-1.44

FitLife Brands has higher earnings, but lower revenue than Jushi. Jushi is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent recommendations for FitLife Brands and Jushi, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0	0	2	1	3.33
Jushi	1	1	0	0	1.50

FitLife Brands presently has a consensus price target of $20.50, suggesting a potential upside of 31.75%. Given FitLife Brands’ stronger consensus rating and higher possible upside, research analysts plainly believe FitLife Brands is more favorable than Jushi.

Summary

FitLife Brands beats Jushi on 13 of the 15 factors compared between the two stocks.

About FitLife Brands

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

About Jushi

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature’s Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.